Box score
Apnimed, Inc.
Reported $25M sold in a new Form D filed March 27, 2026 (Cambridge, Massachusetts).
- Biggest raise
- $25M filed Mar 27, 2026
- League
- Bio & Health Pharmaceuticals
- Based in
- Cambridge, Massachusetts
- Season rank
- #109 of 1,121 in the Bio & Health League; #888 of 10,745 overall (2026)
- Entity
- Corporation
Form D filings since 2024 5
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-03-27 | New notice | $25M | $25M | SEC |
| 2025-12-08 | Amendment | $35M | $35M | SEC |
| 2025-10-01 | Amendment | $35M | $35M | SEC |
| 2025-09-24 | New notice | $23M | $23M | SEC |
| 2025-04-24 | New notice | $16.5M | $16.5M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1745648.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Dash Bio, Inc. | Bio & Health | $30M |
| 2 | Cue Biopharma, Inc. | Bio & Health | $30M |
| 3 | Lonestar Medicines, Inc. rookie | Bio & Health | $25M |
| 4 | Nocion Therapeutics, Inc. | Bio & Health | $23M |
| 5 | Pacegenix, Inc. rookie | Bio & Health | $22.5M |
| 6 | Lifeward Ltd. | Bio & Health | $20M |